Blood News and Research

RSS

UIC's Center for Clinical and Translational Science selects six research projects for new pilot grants

The University of Illinois at Chicago's Center for Clinical and Translational Science has selected six research projects to receive pilot grants in 2013.

15 May 2013

New studies support previous findings that reducing dietary sodium intake improves health

Recent studies that examine links between sodium consumption and health outcomes support recommendations to lower sodium intake from the very high levels some Americans consume now, but evidence from these studies does not support reduction in sodium intake to below 2,300 mg per day, says a new report from the Institute of Medicine.

15 May 2013

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).

15 May 2013

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

On May 10, the U.S. Food and Drug Administration approved Nymalize, a new nimodipine oral solution, to treat patients experiencing symptoms resulting from ruptured blood vessels in the brain (subarachnoid hemorrhage).

15 May 2013

TGen joins Riddell to advance athlete concussion detection and treatment

Head protection plays a vital role in the health and safety of any athlete participating in helmeted sports. In a move that could help revolutionize football player safety, the Translational Genomics Research Institute, and Easton-Bell Sports through its Riddell brand, announced today it would work together on a study designed to advance athlete concussion detection and treatment.

15 May 2013

LDL cholesterol blood level declines found to have abruptly ended in 2008

Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE.

From Quest Diagnostics 14 May 2013

Researchers show how cells are driven mainly by water power

Water gives life. Researchers at Linköping University in Sweden now show how the cells in our bodies are driven mainly by water power - a discovery that in the long run opens the way for a new strategy in cancer therapy.

14 May 2013

Reverse Medical announces initial clinical use of MVP system for peripheral artery embolization

Reverse Medical Corporation today announced the initial clinical use of their MVP Micro Vascular Plug system for peripheral artery embolization. The device has been granted CE Mark approval to obstruct or reduce the rate of blood flow in the peripheral vasculature.

14 May 2013

Research findings have implications for understanding how to slow spread of dengue virus

Researchers have identified the dose of dengue virus in human blood that is required to infect mosquitoes when they bite. Mosquitoes are essential for transmitting the virus between people so the findings have important implications for understanding how to slow the spread of the disease.

14 May 2013

Renaissance in drug development for rare diseases

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ramping up research efforts and marketing new medicines that promise fuller lives for children and other patients with these heartbreaking conditions.

14 May 2013

Inhibiting powerful protein with new agents may supply broad benefit for lymphoma patients

A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein.

14 May 2013

Annual Century for the Cure bike ride supports research on hematologic malignancies

The annual Century for the Cure bike ride that has raised more than $1 million since 2005 for research at The Cancer Institute of New Jersey is now making it possible for new scientific exploration in the area of hematologic malignancies.

14 May 2013

Study suggests that a blood protein contributes to early development of atherosclerosis

It's on Saturday that the Journal of the American Heart Association published the conclusive results from a study directed by Dr. Éric Thorin of the Montreal Heart Institute (MHI), which suggests for the first time that a blood protein contributes to the early development of atherosclerosis.

14 May 2013

Processed and fast food salt levels remain high as ever, new study reports

The dangerously high salt levels in processed food and fast food remain essentially unchanged, despite numerous calls from public and private health agencies for the food industry to voluntarily reduce sodium levels, reports a new Northwestern Medicine study conducted with the Center for Science in the Public Interest.

14 May 2013

Understanding different forms of hepatitis

It's Hepatitis Awareness Month. Understanding the different forms of hepatitis, who is at risk and how it can be prevented and treated can be confusing.

14 May 2013

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found a combination of drugs to potentially treat chronic lymphocytic leukemia more effectively.

14 May 2013

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia, or CN-AML).

14 May 2013

$COSIRA trial: Enrollment complete for assessing Neovasc Reducer in refractory angina patients$

COSIRA trial: Enrollment complete for assessing Neovasc Reducer in refractory angina patients

Neovasc Inc., today announced the completion of patient enrollment in its COSIRA trial designed to further assess the efficacy and safety of the Neovasc Reducer, a novel percutaneous device for the treatment of refractory angina.

13 May 2013

TriStar Wellness Solutions completes acquisition of HemCon Medical Technologies

TriStar Wellness Solutions, Inc., a health and wellness company that targets opportunities in the self-care and professional marketplace, has acquired HemCon Medical Technologies Inc., a Portland, Oregon-based leading researcher and manufacturer of products for bleeding and wound management.

13 May 2013

Telcare receives CE Mark approval to market mHealth glucose meter in the European Union

Telcare, Inc., the leader in mobile diabetes management solutions, today announced it has received CE Mark approval to market its cellular-enabled blood glucose meter, the first FDA-cleared mHealth glucose meter, in the European Union.

13 May 2013

Blood News and Research

UIC's Center for Clinical and Translational Science selects six research projects for new pilot grants

New studies support previous findings that reducing dietary sodium intake improves health

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

TGen joins Riddell to advance athlete concussion detection and treatment

LDL cholesterol blood level declines found to have abruptly ended in 2008

Researchers show how cells are driven mainly by water power

Reverse Medical announces initial clinical use of MVP system for peripheral artery embolization

Research findings have implications for understanding how to slow spread of dengue virus

Renaissance in drug development for rare diseases

Inhibiting powerful protein with new agents may supply broad benefit for lymphoma patients

Annual Century for the Cure bike ride supports research on hematologic malignancies

Study suggests that a blood protein contributes to early development of atherosclerosis

Processed and fast food salt levels remain high as ever, new study reports

Understanding different forms of hepatitis

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

COSIRA trial: Enrollment complete for assessing Neovasc Reducer in refractory angina patients

TriStar Wellness Solutions completes acquisition of HemCon Medical Technologies

Telcare receives CE Mark approval to market mHealth glucose meter in the European Union

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News